Thermo Fisher Scientific Receives Early Termination of Hart-Scott-Rodino Waiting Period for Acquisition of Finesse Solutions, Inc.

Monday, February 13, 2017 9:15 am EST

Dateline:

WALTHAM, Mass.

Public Company Information:

NYSE:
TMO
"Finesse Solutions has been a technology partner since 2013, and we are pleased to add their complementary capabilities to our leading bioproduction offering"

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that its pending acquisition of Finesse Solutions, Inc., a leader in the development of scalable control automation systems and software for bioproduction, has received early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. Thermo Fisher expects to complete the acquisition in the coming days.

Based in Santa Clara, California, Finesse Solutions is a leader in bioprocess management technology, generating approximately $50 million in revenue in 2016. Its proprietary Smart™ technology, which consists of sensors, controllers and software, is designed to optimize the bioproduction workflow. The business will be integrated into Thermo Fisher’s Life Sciences Solutions Segment. Terms of the transaction were not disclosed.

“Finesse Solutions has been a technology partner since 2013, and we are pleased to add their complementary capabilities to our leading bioproduction offering,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “Finesse Solutions has developed a universal control system that will combine seamlessly with our existing single-use technologies to strengthen our position in the high-growth bioproduction market.”

“We are excited to join Thermo Fisher Scientific, and look forward to leveraging the company’s strength and reach to accelerate the development and commercialization of our Smart technology platform,” added Dr. Barbara Paldus, CEO and co-founder of Finesse Solutions.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE:TMO) is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

Contact:

Thermo Fisher Scientific
Media:
Ron O’Brien, 781-622-1242
ron.obrien@thermofisher.com
www.thermofisher.com
or
Investors:
Ken Apicerno, 781-622-1294
ken.apicerno@thermofisher.com

Thermo Fisher Tweets

we're sorry to hear about your experience. Please email us at social.media@thermofisher.com so we can assist you.-2 hours 32 min ago
Restriction enzymes are helpful tools in genomic analysis. Where do you use restriction enzymes besides cloning?… https://t.co/eTDqgVSyQQ-1 day 22 hours ago
RT : Find out when Direct PCR is right for your workflow. Register for our upcoming webinar to find out!… https://t.co/QnYdNvOCvm-2 days 3 hours ago
Our pleasure! Thank you for the lovely pics!-2 days 4 hours ago
Our pleasure!-2 days 4 hours ago